热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-mouse/human CD44 Antibody
产品名称：
Purified anti-mouse/human CD44 Antibody
产品类别：
抗体
产品编号：
103001
产品应用：
103001
[价格]
规格 价格 库存
50µg ￥ 504 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF? - Verified
ELISA, ICC, IHC-P, IP, CMCD, Stim - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for?immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  24. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  2. Kobayashi A, et al. 2021. Front Immunol. 12:650856. PubMed
  3. Villafranca C, et al. 2020. Cytotechnology. . PubMed
  4. Zhang S, et al. 2017. Nature.. 10.1038/nature24283. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  7. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  8. Reeves PM, et al. 2017. Oncotarget. 8:94040. PubMed
  9. Shirakawa K, et al. 2017. PLoS One. 12:e0186303. PubMed
  10. Suzuki K, et al. 2019. Cell Mol Gastroenterol Hepatol. 8:119. PubMed
  11. Yang J, et al. 2020. Front Immunol. 10:3048. PubMed
  12. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  13. Emmerson E et al. 2017. eLife. 6 pii: e26620. PubMed
  14. Min CK, et al. 2018. Front Immunol. 1.779166667. PubMed
  15. Dubrot J, et al. 2018. Life Sci Alliance. 1:e201800164. PubMed
  16. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  17. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  18. He N 2005. J Immunol. 174:6967. PubMed
  19. Haque M, et al. 2021. Viruses. 13:. PubMed
  20. Mayer JU, et al. 2020. Front Immunol. 11:592325. PubMed
  21. Son YM, et al. 2020. Eur J Immunol. 50:1067. PubMed
  22. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  23. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  24. Walker F, et al. 2011. PLoS One. 6:e22733. PubMed
  25. Yamazaki J, et al. 2009. Blood. 114:2709. PubMed
  26. Frank N, et al. 2005. Cancer Res. 65:4320. PubMed
  27. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  28. Noguerol J, et al. 2019. Biol Sex Differ. 10:47. PubMed
  29. Hinohara K, et al. 2018. Cancer Cell. 34:939. PubMed
  30. Hirokawa Y, et al. 2014. Am J Physiol Gastrointest Liver Physiol. 306:547. PubMed
  31. Lee JH, et al. 2022. iScience. 25:104166. PubMed
  32. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  33. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  34. Muhammad F, et al. 2020. Front Immunol. 975:11. PubMed
  35. Tan L, et al. 2017. Int J Nanomedicine. 12:3095. PubMed
  36. Kaisar MMM, et al. 2018. PLoS Biol. 16:e2005504. PubMed
  37. Taylor NA, et al. 2017. J Clin Invest. 127:3472. PubMed
  38. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  39. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  40. Doorduijn EM, et al. 2018. Front Immunol. 0.416666667. PubMed
  41. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  42. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  43. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  44. Pace JA, et al. 2021. Sci Adv. 7:eabg6600. PubMed
  45. Ghanei Z, et al. 2020. Journal of Cellular Physiology. 235(11):7840-7848. PubMed
  46. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  47. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  48. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  49. Lai JF, et al. 2020. J Allergy Clin Immunol. 146:1406. PubMed
  50. Xie D, et al. 2020. Eur J Immunol. 50:1729. PubMed
  51. Tan Z, et al. 2020. Mol Ther Oncolytics. 16:302. PubMed
  52. Sato Y, et al. 2021. BMC Cancer. 21:1222. PubMed
  53. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  54. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  55. Bittner-Eddy PD, et al. 2020. Front Immunol. 11:677. PubMed
  56. Khairnar V, et al. 2018. Nat Commun. 2.153472222. PubMed
  57. Kim SJ, et al. 2017. Nat Immunol. 18:1016. PubMed
  58. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  59. Wang D, et al. 2019. Cancers (Basel). 11. PubMed
  60. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  61. You X, et al. 2022. Front Genet. 12:790990. PubMed
  62. Emmerson E, et al. 2018. EMBO Mol Med. 10.15252/emmm.201708051. PubMed
  63. Zhou Z, et al. 2018. Cancer Res. 78:2248. PubMed
  64. Lee JY, et al. 2018. Front Immunol. 0.678472222. PubMed
  65. Liu M, et al. 2018. Diabetologia. 61:2333. PubMed
  66. Heng WS, et al. 2021. Lung Cancer. 154:13. PubMed
  67. Tang F, et al. 2015. Sci Signal. 8: ra100. PubMed
  68. Kenna T, et al. 2008. Blood. 111:2091. PubMed
  69. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  70. Yates K, et al. 2018. Proc Natl Acad Sci U S A. 115:2162. PubMed
  71. Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
  72. Klingler S, et al. 2022. JCI Insight. 7:. PubMed
  73. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  74. Tan CL, et al. 2018. Immunohorizons. 0.248611111. PubMed
  75. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  76. Fujimoto N, et al. 2020. PLoS Biol. 18:e3000704. PubMed
  77. Karmaus PWF, et al. 2019. Nature. 565:101. PubMed
  78. Flietner E, et al. 2022. Sci Rep. 12:10616. PubMed
  79. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  80. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  81. Meyers JL, et al. 2018. PLoS One. 13:e0207007. PubMed
  82. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  83. Heijink A, et al. 2015. Proc Natl Acad Sci U S A. 112: 15160 - 15165. PubMed
  84. Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
  85. Yi J, et al. 2019. Mol Cells. 42:228. PubMed
  86. Wang X, et al. 2008. Blood. 111:2436. PubMed
  87. Arkatkar T, et al. 2018. Kidney Int. 94:728. PubMed
  88. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  89. Cui X, et al. 2017. J Immunol. 199:4066. PubMed
  90. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  91. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  92. Jun JC, et al. 2017. PLoS One. 12:e0180688. PubMed
  93. Nguyen H, et al. 2020. Clin Cancer Res. 26:3481. PubMed
  94. Karuppuchamy T, et al. 2020. Inflamm Bowel Dis. 216:26. PubMed
  95. Gui J, et al. 2007. Int Immunol. 1.625694444. PubMed
  96. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  97. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  98. Ding L, et al. 2019. Nat Commun. 10:4182. PubMed
  99. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  100. Bordoloi D, et al. 2021. Genes Cancer. 12:51. PubMed
  101. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  102. K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  103. Prabakaran T, et al. 2021. EBioMedicine. 66:103314. PubMed
  104. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
  105. Guo Y, et al. 2018. J Am Soc Nephrol. 29:2529. PubMed
RRID
AB_312952 (BioLegend Cat. No. 103001) AB_312953 (BioLegend Cat. No. 103002)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
UniProt
View information about CD44 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线